References
- Capell BC, Erdos MR, Madigan JP, Fiordalisi JJ, Varga R, Conneely KN, Gordon LB, Der CJ, Cox AD, Collins FS. (2003). Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 102(36): 12879-12884.
- Capell BC, Olive M, Erdos MR, Cao K, Faddah DA, Tavarez UL, Conneely KN, Qu X, San H, Ganesh SK, Chen X, Avallone H, Kolodgie FD, Virmani R, Nabel EG, Collins FS. (2008). A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc Natl Acad Sci U S A 105(41): 15902-15907.
- Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ. (2006). Nuclear Lamins: Laminopathies and Their Role in Premature Ageing. Physiol Rev 86(3): 967-1008.
- Lippincott-Schwartz J, Patterson GH. (2003). Development and Use of Fluorescent Protein Markers in Living Cells. Science 300: 87-91.
- Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, Brewer CC, Zalewski C, Kim HJ, Solomon B, Brooks BP, Gerber LH, Turner ML, Domingo DL, Hart TC, Graf J, Reynolds JC, Gropman A, Yanovski JA, Gerhard-Herman M, Collins FS, Nabel EG, Cannon RO 3rd, Gahl WA, Introne WJ. (2008). Phenotype and Course of Hutchinson-Gilford Progeria Syndrome. N Engl J Med 358(6): 592-604.
- Scaffidi P, Misteli T. (2005). Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford Progeria Syndrome. Nat Med 11: 440-445.
- Worman HJ, Östlund C, Wang Y. (2010). Diseases of the Nuclear Envelope. Cold Spring Harb Perspect Biol. 2(2): a000760.